SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer
The emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), in December 2019 led to a worldwide pandemic with over 170 million confirmed infections and over 3.5 million deaths (as of May 2021). Early studies have shown higher mortality rates from SARS-CoV-2 in...
Main Authors: | Mark C. Howell, Ryan Green, Andrew R. McGill, Rinku Dutta, Subhra Mohapatra, Shyam S. Mohapatra |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/11/2676 |
Similar Items
-
Microbiome, gut dysbiosis and inflammatory bowel disease: That moment when the function is more important than taxonomy
by: S. I. Sitkin, et al.
Published: (2018-11-01) -
Gut-joint axis: Gut dysbiosis can contribute to the onset of rheumatoid arthritis via multiple pathways
by: María del Socorro Romero-Figueroa, et al.
Published: (2023-01-01) -
Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study
by: Vanessa Stadlbauer, et al.
Published: (2020-07-01) -
Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
by: Rinku Dutta, et al.
Published: (2021-07-01) -
Sodium butyrate in both prevention and supportive treatment of colorectal cancer
by: Karolina Kaźmierczak-Siedlecka, et al.
Published: (2022-10-01)